Montu lodged a formal submission to the Productivity Commission’s national inquiry into data, digital technology and care delivery, calling for nationally consistent regulation to support initiatives including telehealth, AI and prescribing.
Montu’s vice-president of corporate affairs and patient advocacy, Jodie Thomas, said “inconsistent requirements across states” had created unnecessary complexity for patients and providers, ultimately slowing care delivery.
While digital tools such as telehealth and AI offered clear benefits in reducing costs and improving access, Montu warned fragmented state-based regulation had limited their impact.
The company urged governments to establish nationally aligned frameworks to support responsible innovation and better meet the needs of patients.
As part of its submission, Montu called for streamlined prescribing rules, formal recognition of telehealth as preventative care, clearer AI regulation, and scalable education models. It also advocated for increased investment in digital workforce development.
Cann Group
Cann Group received a second funding advance of more than $315,000 from Radium Capital, providing early access to the company’s expected FY25 R&D tax incentive.
The funding related to R&D activities carried out during March and April 2025, and followed an earlier advance of almost $8490,000 for activities up to the end of February.
The total amount borrowed now stands at about $1,152,000, with repayment due on receipt of the FY25 rebate or by 31 October 2025, whichever comes first.